125 related articles for article (PubMed ID: 15770087)
21. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
[TBL] [Abstract][Full Text] [Related]
22. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
23. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients.
Beser J; Dini L; Botero-Kleiven S; Krabbe M; Lindh J; Hagblom P
Med Mycol; 2012 Apr; 50(3):320-3. PubMed ID: 21732748
[TBL] [Abstract][Full Text] [Related]
24. Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998-2001 prospective study.
Latouche S; Lacube P; Maury E; Bolognini J; Develoux M; Girard PM; Godet C; Lebrette MG; Mayaud C; Guillot J; Roux P
Med Mycol; 2003 Dec; 41(6):533-7. PubMed ID: 14725329
[TBL] [Abstract][Full Text] [Related]
25. Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.
Ma L; Kovacs JA
Antimicrob Agents Chemother; 2001 Mar; 45(3):776-80. PubMed ID: 11181359
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China.
Zhu M; Ye N; Xu J
PLoS One; 2020; 15(9):e0238184. PubMed ID: 32911508
[TBL] [Abstract][Full Text] [Related]
27. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients.
Liao TY; Huang YT; Lee TF; Hsueh PR; Yu CJ; Chien JY
Int J Antimicrob Agents; 2024 Jan; 63(1):107019. PubMed ID: 37925109
[TBL] [Abstract][Full Text] [Related]
29. [Research progress on genes mutations related to sulfa drug resistance in
Wang M; Zhu B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):563-569. PubMed ID: 29488726
[TBL] [Abstract][Full Text] [Related]
30. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
Kazanjian P; Armstrong W; Hossler PA; Burman W; Richardson J; Lee CH; Crane L; Katz J; Meshnick SR
J Infect Dis; 2000 Aug; 182(2):551-7. PubMed ID: 10915088
[TBL] [Abstract][Full Text] [Related]
31. Dihydropteroate synthase gene mutation rates in Pneumocystis jirovecii strains obtained from Iranian HIV-positive and non-HIV-positive patients.
Sheikholeslami MF; Sadraei J; Farnia P; Forozandeh Moghadam M; Emadikochak H
Med Mycol; 2015 May; 53(4):361-8. PubMed ID: 25631478
[TBL] [Abstract][Full Text] [Related]
32. Update on Dihydropteroate Synthase (DHPS) Mutations in
de la Horra C; Friaza V; Morilla R; Delgado J; Medrano FJ; Miller RF; de Armas Y; Calderón EJ
J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682277
[TBL] [Abstract][Full Text] [Related]
33. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates.
Demanche C; Guillot J; Berthelemy M; Petitt T; Roux P; Wakefield AE
Med Mycol; 2002 Jun; 40(3):315-8. PubMed ID: 12146763
[TBL] [Abstract][Full Text] [Related]
34. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia.
Rabodonirina M; Vaillant L; Taffé P; Nahimana A; Gillibert RP; Vanhems P; Hauser PM
Emerg Infect Dis; 2013 Jan; 19(1):21-8; quiz 186. PubMed ID: 23260763
[TBL] [Abstract][Full Text] [Related]
35. [Genotypic resistance to sulfamide drugs among patients with Pneumocystis jiroveci pneumonia].
Calderón E; de la Horra C; Montes-Cano MA; Respaldiza N; Martín-Juan J; Varela JM
Med Clin (Barc); 2004 May; 122(16):617-9. PubMed ID: 15142509
[TBL] [Abstract][Full Text] [Related]
36. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients.
Wissmann G; Alvarez-Martinez MJ; Meshnick SR; Dihel AR; Prolla JC
J Eukaryot Microbiol; 2006; 53(4):305-7. PubMed ID: 16872298
[TBL] [Abstract][Full Text] [Related]
37. Dihydropteroate synthase and novel dihydrofolate reductase gene mutations in strains of Pneumocystis jirovecii from South Africa.
Robberts FJ; Chalkley LJ; Weyer K; Goussard P; Liebowitz LD
J Clin Microbiol; 2005 Mar; 43(3):1443-4. PubMed ID: 15750128
[TBL] [Abstract][Full Text] [Related]
38. Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.
Nahimana A; Rabodonirina M; Helweg-Larsen J; Meneau I; Francioli P; Bille J; Hauser PM
Emerg Infect Dis; 2003 Jul; 9(7):864-7. PubMed ID: 12890330
[TBL] [Abstract][Full Text] [Related]
39. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia.
Visconti E; Ortona E; Mencarini P; Margutti P; Marinaci S; Zolfo M; Siracusano A; Tamburrini E
Int J Antimicrob Agents; 2001 Dec; 18(6):547-51. PubMed ID: 11738342
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a mutationally altered dihydropteroate synthase contributing to sulfathiazole resistance in Escherichia coli.
Vedantam G; Nichols BP
Microb Drug Resist; 1998; 4(2):91-7. PubMed ID: 9650994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
